These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35410491)

  • 1. Effect of Lipoprotein(a) on Stroke Recurrence Attenuates at Low LDL-C (Low-Density Lipoprotein) and Inflammation Levels.
    Xu J; Hao X; Zhan R; Jiang X; Jin A; Xue J; Cheng A; Liu J; Lin J; Meng X; Li H; Zheng L; Wang Y
    Stroke; 2022 Aug; 53(8):2504-2511. PubMed ID: 35410491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Contribution of Inflammation to Stroke Recurrence Attenuates at Low LDL-C Levels.
    Zhang X; Lv W; Xu J; Li J; Pan Y; Yan H; Li H; Li Z; Meng X; Wang Y
    J Atheroscler Thromb; 2022 Nov; 29(11):1634-1645. PubMed ID: 35013023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual Inflammatory Risk Predicts Poor Prognosis in Acute Ischemic Stroke or Transient Ischemic Attack Patients.
    Li J; Pan Y; Xu J; Li S; Wang M; Quan K; Meng X; Li H; Lin J; Wang Y; Zhao X; Liu L; Wang Y;
    Stroke; 2021 Aug; 52(9):2827-2836. PubMed ID: 34281380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 and YKL-40 predicted recurrent stroke after ischemic stroke or TIA: analysis of 6 inflammation biomarkers in a prospective cohort study.
    Li J; Lin J; Pan Y; Wang M; Meng X; Li H; Wang Y; Zhao X; Qin H; Liu L; Wang Y;
    J Neuroinflammation; 2022 Jun; 19(1):131. PubMed ID: 35761288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidized low-density lipoprotein (LDL) and LDL cholesterol are associated with outcomes of minor stroke and TIA.
    Wang A; Dai L; Zhang N; Lin J; Chen G; Zuo Y; Li H; Wang Y; Meng X; Wang Y
    Atherosclerosis; 2020 Mar; 297():74-80. PubMed ID: 32097804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a), high-sensitivity C-reactive protein, and cardiovascular risk in patients undergoing percutaneous coronary intervention.
    Yuan D; Wang P; Jia S; Zhang C; Zhu P; Jiang L; Liu R; Xu J; Tang X; Song Y; Yao Y; Xu N; Zhang Y; Zhao X; Yang Y; Xu B; Gao L; Gao Z; Gao R; Yuan J
    Atherosclerosis; 2022 Dec; 363():109-116. PubMed ID: 36357218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) and functional outcome of acute ischemic stroke when discordant with low-density lipoprotein cholesterol.
    Dong W; Zhong X; Yuan K; Miao M; Zhai Y; Che B; Xu T; Xu X; Zhong C
    Postgrad Med J; 2023 Oct; 99(1177):1160-1166. PubMed ID: 37624118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting.
    Verbeek R; Hoogeveen RM; Langsted A; Stiekema LCA; Verweij SL; Hovingh GK; Wareham NJ; Khaw KT; Boekholdt SM; Nordestgaard BG; Stroes ESG
    Eur Heart J; 2018 Jul; 39(27):2589-2596. PubMed ID: 29931232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between High-Sensitivity C-Reactive Protein and Prognosis in Different Periods After Ischemic Stroke or Transient Ischemic Attack.
    Wang Y; Li J; Pan Y; Wang M; Meng X; Wang Y
    J Am Heart Assoc; 2022 Jul; 11(13):e025464. PubMed ID: 35766270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of the commonest residual risk factors, remnant cholesterol, lipoprotein(a), and inflammation, on prognosis of statin-treated patients with chronic coronary syndrome.
    Liu HH; Guo YL; Zhu CG; Wu NQ; Gao Y; Xu RX; Dong Q; Qian J; Dou KF; Li JJ
    J Transl Med; 2022 May; 20(1):243. PubMed ID: 35619146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromes.
    Gencer B; Rigamonti F; Nanchen D; Vuilleumier N; Kern I; Aghlmandi S; Klingenberg R; Räber L; Auer R; Carballo D; Carballo S; Heg D; Windecker S; Lüscher TF; Matter CM; Rodondi N; Mach F
    Eur J Clin Invest; 2019 Jul; 49(7):e13117. PubMed ID: 30937890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Rikhi R; Hammoud A; Ashburn N; Snavely AC; Michos ED; Chevli P; Tsai MY; Herrington D; Shapiro MD
    Atherosclerosis; 2022 Dec; 363():102-108. PubMed ID: 36253168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-Density Lipoprotein Cholesterol and Risk of Recurrent Vascular Events in Chinese Patients With Ischemic Stroke With and Without Significant Atherosclerosis.
    Lau KK; Chua BJ; Ng A; Leung IY; Wong YK; Chan AH; Chiu YK; Chu AX; Leung WCY; Tsang AC; Teo KC; Mak HK
    J Am Heart Assoc; 2021 Aug; 10(16):e021855. PubMed ID: 34369170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cumulative Effects of LDL Cholesterol and CRP Levels on Recurrent Stroke and TIA.
    Kitagawa K; Hosomi N; Nagai Y; Kagimura T; Ohtsuki T; Maruyama H; Origasa H; Minematsu K; Uchiyama S; Nakamura M; Matsumoto M;
    J Atheroscler Thromb; 2019 May; 26(5):432-441. PubMed ID: 30318492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 genotypes modulate the long-term effect of lipoprotein(a) on cardiovascular events: The Ioannina Study.
    Naka KK; Bechlioullis A; Marini A; Sionis D; Vakalis K; Triantis G; Wilkins L; Rogus J; Kornman KS; Witztum JL; Doucette-Stamm L; Michalis LK; Tsimikas S
    J Clin Lipidol; 2018; 12(2):338-347. PubMed ID: 29310992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory cytokines, high-sensitivity C-reactive protein, and risk of one-year vascular events, death, and poor functional outcome after stroke and transient ischemic attack.
    Coveney S; Murphy S; Belton O; Cassidy T; Crowe M; Dolan E; de Gaetano M; Harbison J; Horgan G; Marnane M; McCabe JJ; Merwick A; Noone I; Williams D; Kelly PJ
    Int J Stroke; 2022 Feb; 17(2):163-171. PubMed ID: 33538655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a) Interactions With Low-Density Lipoprotein Cholesterol and Other Cardiovascular Risk Factors in Premature Acute Coronary Syndrome (ACS).
    Afshar M; Pilote L; Dufresne L; Engert JC; Thanassoulis G
    J Am Heart Assoc; 2016 Apr; 5(4):. PubMed ID: 27108248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations.
    Small AM; Pournamdari A; Melloni GEM; Scirica BM; Bhatt DL; Raz I; Braunwald E; Giugliano RP; Sabatine MS; Peloso GM; Marston NA; Natarajan P
    JAMA Cardiol; 2024 Apr; 9(4):385-391. PubMed ID: 38353970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory and Cholesterol Risk in the FOURIER Trial.
    Bohula EA; Giugliano RP; Leiter LA; Verma S; Park JG; Sever PS; Lira Pineda A; Honarpour N; Wang H; Murphy SA; Keech A; Pedersen TR; Sabatine MS
    Circulation; 2018 Jul; 138(2):131-140. PubMed ID: 29530884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease.
    Jürgens G; Taddei-Peters WC; Költringer P; Petek W; Chen Q; Greilberger J; Macomber PF; Butman BT; Stead AG; Ransom JH
    Stroke; 1995 Oct; 26(10):1841-8. PubMed ID: 7570736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.